A REPEAT DOSE STUDY WITH GSK1018921 TO ASSESS SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS IN HEALTHY VOLUNTEERS AND PATIENTS WITH SCHIZOPHRENIA AND TO EVALUATE ITS EFFECT ON PK OF MIDAZOLAM.: